Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jun 1;46(11):1694-701.
doi: 10.1086/587667.

Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy

Affiliations

Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy

Andrew Kambugu et al. Clin Infect Dis. .

Abstract

Background: Cryptococcal meningitis (CM) is the proximate cause of death in 20%-30% of persons with acquired immunodeficiency syndrome in Africa.

Methods: Two prospective, observational cohorts enrolled human immunodeficiency virus (HIV)-infected, antiretroviral-naive persons with CM in Kampala, Uganda. The first cohort was enrolled in 2001-2002 (n = 92), prior to the availability of highly active antiretroviral therapy (HAART), and the second was enrolled in 2006-2007 (n = 44), when HAART was available.

Results: Ugandans presented with prolonged CM symptoms (median duration, 14 days; interquartile range, 7-21 days). The 14-day survival rates were 49% in 2001-2002 and 80% in 2006 (P < .001). HAART was started 35 +/- 13 days after CM diagnosis and does not explain the improved 14-day survival rate in 2006. In 2006-2007, the survival rate continued to decrease after hospitalization, with only 55% surviving to initiate HAART as an outpatient. Probable cryptococcal-related immune reconstitution inflammatory syndrome occurred in 42% of patients, with 4 deaths. At 6 months after CM diagnosis, 18 persons (41%) were alive and receiving HAART in 2007. The median cerebral spinal fluid (CSF) opening pressure was 330 mm H(2)O; 81% of patients had elevated pressure (>200 mm H(2)O). Only 5 patients consented to therapeutic lumbar puncture. There was a trend for higher mortality for pressures >250 mm H(2)O (odds ratio [OR], 2.1; 95% confidence interval [CI], 0.9-5.2; P = .09). Initial CSF WBC counts of <5 cells/mL were associated with failure of CSF sterilization (OR, 17.3; 95% CI, 3.1-94.3; P < .001), and protein levels <35 mg/dL were associated with higher mortality (OR, 2.0; 95% CI, 1.2-3.3; P = .007).

Conclusions: Significant CM-associated mortality persists, despite the administration of amphotericin B and HIV therapy, because of the high mortality rate before receipt of HAART and because of immune reconstitution inflammatory syndrome-related complications after HAART initiation. Approaches to increase acceptance of therapeutic lumbar punctures are needed.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: No conflicts of interest exist.

Figures

Figure 1
Figure 1
Figure 1a. Study Profile Pre-HAART Era, 2001–2002. Figure 1b. Study Profile in the HAART Era, 2006.
Figure 1
Figure 1
Figure 1a. Study Profile Pre-HAART Era, 2001–2002. Figure 1b. Study Profile in the HAART Era, 2006.
Figure 2
Figure 2
Kaplan-Meier survival curves stratified by time period
Figure 3
Figure 3
Distribution of CSF Opening Pressure in 126 HIV-infected Patients with Cryptococcal Meningitis (2001 and 2006)

Similar articles

Cited by

References

    1. Hakim JG, Gangaidzo IT, Heyderman RS, et al. Impact of HIV infection on meningitis in Harare, Zimbabwe: a prospective study of 406 predominantly adult patients. AIDS. 2000;14:1401–7. - PubMed
    1. “3 by 5” Progress Report: December 2003-June 2004, July 2004 WHO Publication

    1. Chuck SL, Sande MA. Infection with Cryptococcus neoformans in the Acquired Immunodeficiency Syndrome. N Engl J Med. 1989;231:794–9. - PubMed
    1. French N, Gray K, Watera C, et al. Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults. AIDS. 2002;16:1031–8. - PubMed
    1. Sacktor N, Lyles RH, Skolasky MA, et al. HIV-associated neurologic diseases incidence changes: Multicenter AIDS cohort Study, 1990–1998. Neurology. 2001;56:257–260. - PubMed

Publication types

MeSH terms